Enfusion ENFN Stock
Enfusion Price Chart
Enfusion ENFN Financial and Trading Overview
| Enfusion stock price | 9.57 USD |
| Previous Close | 8.89 USD |
| Open | 8.79 USD |
| Bid | 8.01 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 8.66 - 8.92 USD |
| 52 Week Range | 7.37 - 16.76 USD |
| Volume | 458.23K USD |
| Avg. Volume | 385.12K USD |
| Market Cap | 666.03M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 221.75 |
| EPS (TTM) | 0.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.08 USD |
ENFN Valuation Measures
| Enterprise Value | 662.02M USD |
| Trailing P/E | 221.75 |
| Forward P/E | 31.678572 |
| PEG Ratio (5 yr expected) | 0.55 |
| Price/Sales (ttm) | 4.2373676 |
| Price/Book (mrq) | 10.313953 |
| Enterprise Value/Revenue | 4.212 |
| Enterprise Value/EBITDA | 69.915 |
Trading Information
Enfusion Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -10.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.76 USD |
| 52 Week Low | 7.37 USD |
| 50-Day Moving Average | 8.56 USD |
| 200-Day Moving Average | 10.63 USD |
ENFN Share Statistics
| Avg. Volume (3 month) | 385.12K USD |
| Avg. Daily Volume (10-Days) | 458.14K USD |
| Shares Outstanding | 75.09M |
| Float | 22.73M |
| Short Ratio | 2.6 |
| % Held by Insiders | 7.35% |
| % Held by Institutions | 104.62% |
| Shares Short | 1.28M |
| Short % of Float | 3.85% |
| Short % of Shares Outstanding | 1.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1.62% |
| Operating Margin (ttm) | 3.23% |
| Gross Margin | 68.55% |
| EBITDA Margin | 6.02% |
Management Effectiveness
| Return on Assets (ttm) | 2.80% |
| Return on Equity (ttm) | 4.03% |
Income Statement
| Revenue (ttm) | 157.18M USD |
| Revenue Per Share (ttm) | 1.81 USD |
| Quarterly Revenue Growth (yoy) | 20.00% |
| Gross Profit (ttm) | 103.25M USD |
| EBITDA | 9.47M USD |
| Net Income Avi to Common (ttm) | 2.54M USD |
| Diluted EPS (ttm) | 0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.6M USD |
| Total Cash Per Share (mrq) | 0.73 USD |
| Total Debt (mrq) | 13.66M USD |
| Total Debt/Equity (mrq) | 13.77 USD |
| Current Ratio (mrq) | 6.322 |
| Book Value Per Share (mrq) | 0.86 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 19.18M USD |
| Levered Free Cash Flow (ttm) | 13.03M USD |
Profile of Enfusion
| Country | United States |
| State | IL |
| City | Chicago |
| Address | 125 South Clark Street |
| ZIP | 60603 |
| Phone | 312 253 9800 |
| Website | https://www.enfusion.com |
| Industry | Software-Application |
| Sector(s) | Technology |
| Full Time Employees | 1006 |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. The company was founded in 1997 and is headquartered in Chicago, Illinois.
Q&A For Enfusion Stock
What is a current ENFN stock price?
Enfusion ENFN stock price today per share is 9.57 USD.
How to purchase Enfusion stock?
You can buy ENFN shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enfusion?
The stock symbol or ticker of Enfusion is ENFN.
Which industry does the Enfusion company belong to?
The Enfusion industry is Software-Application.
How many shares does Enfusion have in circulation?
The max supply of Enfusion shares is 89.87M.
What is Enfusion Price to Earnings Ratio (PE Ratio)?
Enfusion PE Ratio is 136.71428000 now.
What was Enfusion earnings per share over the trailing 12 months (TTM)?
Enfusion EPS is 0.07 USD over the trailing 12 months.
Which sector does the Enfusion company belong to?
The Enfusion sector is Technology.
Enfusion ENFN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}